Notice of AGM

RNS Number : 8515C

Futura Medical PLC

20 April 2017

 

For immediate release

20 April 2017

Futura Medical plc

("Futura" or "the Company")

Notice of AGM

Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology, announces that its notice of Annual General Meeting ("AGM"), including Explanatory Notes and Form of Proxy, has today been posted to shareholders. The AGM will be held at 4.00pm on 14 June 2017 at the offices of Buchanan, 107 Cheapside, London EC2V 6DN.

Futura's annual report and accounts for the year ended 31 December 2016 (the "Annual Report") is available to shareholders as an electronic communication pursuant to the Companies Act 2006 and is now available at the Company's website www.futuramedical.com, along with the notice of AGM. Copies of the Annual Report have today been posted to shareholders who have opted out of receiving electronic communications. Shareholders who would like to attend the AGM are invited to contact Buchanan on 020 7466 5000 or email [e-mail].

For any further information please contact:

Futura Medical plc
James Barder, Chief Executive	Tel: [phone]
mail to: [e-mail]	www.futuramedical.com
N+1 Singer (Nominated Adviser and Broker)
Aubrey Powell / Liz Yong	Tel:[phone]
For media enquiries please contact:
Buchanan
Mark Court / Sophie Cowles / Stephanie Watson	Tel: [phone]

Notes to Editors

Futura Medical plc

Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.

Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.

www.futuramedical.com

 

END

 

 

NOAURSWRBAASURR